Skip to main content

Eversept Partners, LP

SEC CIK
0001697013
Latest filing
Aug 14, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q2 2025
Holdings of NKTR by Eversept Partners, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−49,890−100.0%Sold outHolders
Q3 202549,890$2.84M0.2%−65,110−56.6%ReducedHolders
Q2 2025115,000$2.97M0.3%+115,000NewHolders